Britannia will supply
Apokyn to patients through US-based USWorldMeds, which will offer the drug in the US as of December, Ipsen said on Thursday.
An alternative to
Apokyn in approaching the problem of off episodes is rasagiline, a potent once-daily second-generation MAO type-B inhibitor.
Side effects more common with
Apokyn were yawning, dizziness, nausea, sleepiness, and dyskinesias, all of which were mostly mild to moderate in intensity.
An alternative to
Apokyn in approaching the problem of off episodes is rasagiline, a potent once daily second generation MAO type-B inhibitor that reduces the frequency of such episodes by blocking dopamine breakdown, although it's not useful as rescue therapy during an episode.
